A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Clinical trial NCT04319367 · RECRUITING

Trial details

NCT number: NCT04319367
Sponsor: Imperial College London
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV/AIDS and Infections

Start date: 2021-05-17
Primary completion: 2027-07-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.